Global Markets for Infectious Disease Treatments to Grow to $96.8 Billion by 2017
Infectious diseases are major causes of death around the world. Viral, bacterial, parasitic, and fungal diseases have plagued humankind for centuries, and attempts to control these diseases have met with great success, as many fatal diseases are now chronic and manageable.
The global market for vaccine, and treatment products is being driven by emerging markets in the BRIC (i.e., Brazil, Russia, India, and China) countries, with children the most vulnerable group.
In spite of numerous technological advancements, microbes have transformed themselves to outwit current medications. The constant combining and reinventing of microbes calls for improved antibiotic and viral medications to sustain the progress made in addressing the most aggressive of theses diseases.
BCC Research has published a report. According to BCC's report, the global market for infectious disease diagnostic, vaccine, and pharmaceutical products was valued at $59.2 billion in 2011 and $66.4 billion in 2012. The report expects promising market growth, with overall market value to reach $96.8 billion by 2017, after increasing at a compound annual growth rate (CAGR) of 7.8%.
The report provides a detailed analysis of the global infectious disease market, with emphasis on seven major infectious diseases (i.e., human immunodeficiency virus/acquired immunodeficiency virus [HIV/AIDS]; hepatitis A, B, C; malaria; rotavirus/diarrhea; measles; pneumonia; and tuberculosis [TB]). The report includes a discussion on technological developments, future trends, and emerging opportunities.
This BCC Research market report organizes information from diverse sources into a cohesive unit that includes an overview, global implications of infectious diseases, infectious diseases by type, treatment and prevention, emerging pharmaceutical and diagnostic products, and an applicable patents section.
The information presented through this report is organized by type of infectious disease (i.e., bacterial, viral, parasitic) and appropriate treatments, both current and anticipated; major players in the marketplace; market conditions; and current and projected revenues.
This updated report on the infectious diseases market and technologies will be a valuable tool for decision makers and manufacturers in both the diagnostic and the pharmaceutical treatment industries. Individuals at research foundations, manufacturing companies, and university laboratories will find valuable information on the global diagnostic product and pharmaceutical industries. This information also is useful for individuals involved in strategic planning and marketing and sales development.
BCC Research is a leading information resource producing high-quality market research reports, newsletters, and conferences.For more information about this report, call (781) 489-7301, send an e-mail to help@bccresearch.com, or click here to purchase the report.
The global market for vaccine, and treatment products is being driven by emerging markets in the BRIC (i.e., Brazil, Russia, India, and China) countries, with children the most vulnerable group.
In spite of numerous technological advancements, microbes have transformed themselves to outwit current medications. The constant combining and reinventing of microbes calls for improved antibiotic and viral medications to sustain the progress made in addressing the most aggressive of theses diseases.
BCC Research has published a report. According to BCC's report, the global market for infectious disease diagnostic, vaccine, and pharmaceutical products was valued at $59.2 billion in 2011 and $66.4 billion in 2012. The report expects promising market growth, with overall market value to reach $96.8 billion by 2017, after increasing at a compound annual growth rate (CAGR) of 7.8%.
The report provides a detailed analysis of the global infectious disease market, with emphasis on seven major infectious diseases (i.e., human immunodeficiency virus/acquired immunodeficiency virus [HIV/AIDS]; hepatitis A, B, C; malaria; rotavirus/diarrhea; measles; pneumonia; and tuberculosis [TB]). The report includes a discussion on technological developments, future trends, and emerging opportunities.
This BCC Research market report organizes information from diverse sources into a cohesive unit that includes an overview, global implications of infectious diseases, infectious diseases by type, treatment and prevention, emerging pharmaceutical and diagnostic products, and an applicable patents section.
The information presented through this report is organized by type of infectious disease (i.e., bacterial, viral, parasitic) and appropriate treatments, both current and anticipated; major players in the marketplace; market conditions; and current and projected revenues.
This updated report on the infectious diseases market and technologies will be a valuable tool for decision makers and manufacturers in both the diagnostic and the pharmaceutical treatment industries. Individuals at research foundations, manufacturing companies, and university laboratories will find valuable information on the global diagnostic product and pharmaceutical industries. This information also is useful for individuals involved in strategic planning and marketing and sales development.
BCC Research is a leading information resource producing high-quality market research reports, newsletters, and conferences.For more information about this report, call (781) 489-7301, send an e-mail to help@bccresearch.com, or click here to purchase the report.